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Abstract
Background: Aedes aegypti and Ae. albopictus are two highly invasive mosquito species, both vectors of several
viruses, including dengue, chikungunya and Zika. While Ae. aegypti is the primary vector in the tropics and sub-tropics,
Ae. albopictus is increasingly under the public health watch as it has been implicated in arbovirus-transmission in more
temperate regions, including continental Europe. Vector control using insecticides is the pillar of most control
programmes; hence development of insecticide resistance is of great concern. As part of a Brazilian-Swiss Joint
Research Programme we set out to assess whether there are any signs of existing or incipient insecticide
resistance primarily against the larvicide Bacillus thuringiensis svar. israelensis (Bti), but also against currently
applied and potentially alternative insecticides in our areas, Recife (Brazil) and the Swiss-Italian border region.
Methods: Following World Health Organization guidelines, dose-response curves for a range of insecticides were
established for both colonized and field caught Ae. aegypti and Ae. albopictus. The larvicides included Bti, two of
its toxins, Cry11Aa and Cry4Ba, Lysinibacillus sphaericus, Vectomax CG®, a formulated combination of Bti and L.
sphaericus, and diflubenzuron. In addition to the larvicides, the Swiss-Italian Ae. albopictus populations were also tested
against five adulticides (bendiocarb, dichlorodiphenyltrichloroethane, malathion, permethrin and λ-cyhalothrin).
Results: Showing a similar dose-response, all mosquito populations were fully susceptible to the larvicides tested and,
in particular, to Bti which is currently used both in Brazil and Switzerland. In addition, there were no signs of incipient
resistance against Bti as larvae were equally susceptible to the individual toxins, Cry11Aa and Cry4Ba. The field-caught
Swiss-Italian populations were susceptible to the adulticides tested but DDT mortality rates showed signs of reduced
susceptibility.
Conclusions: The insecticides currently used for mosquito control in Switzerland and Brazil are still effective against the
target populations. The present study provides an important reference as relatively few insecticide susceptibility surveys
have been carried out with Ae. albopictus.
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Background
Dengue (DENV), chikungunya (CHIKV) and Zika virus
(ZIKV) are mosquito-borne viruses of medical import-
ance in most tropical regions but also emerging in more
temperate regions including continental Europe. Dengue
fever is the most prevalent mosquito-borne disease
worldwide with an estimated 390 million cases per year
[1]. In the Americas, most dengue cases have been re-
ported from Brazil, which has been affected by several
epidemics since the 1990s [2]. In 2016, around 1.5
million cases were reported from all states of the coun-
try [3]. In Brazil Aedes aegypti is the major vector of
dengue and all four DENV serotypes are co-circulating
in the country [4]. In 2014, the first autochthonous chi-
kungunya cases have been detected in Brazil and in 2016
a total of 271,824 confirmed cases have been reported
from several states, including Pernambuco [3]. In 2015,
autochthonous cases of ZIKV were also reported from
Brazil for the first time [5] and 125,319 cases were con-
firmed in 2016 [3]. All the above cases have been linked
to Ae. aegypti, a highly competent vector of arboviruses.
In continental Europe, the most prominent example is
the chikungunya outbreak in Ravenna, Italy in 2007 with
over 200 confirmed cases and one death. The outbreak
was linked to a transmission by the invasive mosquito Ae.
albopictus and a single viraemic person that returned with
chikungunya from India [6]. CHIKV is a mosquito-borne
alphavirus indigenous to African countries, the Indian
subcontinent and Southeast Asia where it causes endemic
and epidemic fever outbreaks [7]. The outbreak in Italy
demonstrates the vector capacity of the local Ae. albopic-
tus population to transmit CHIKV. Following this out-
break, additional cases of autochthonous chikungunya
were recorded in mainland France [8] as well as dengue
cases in both Croatia and France (e.g. [9–11]). These out-
breaks show that continental Europe is vulnerable to the
transmission of “tropical” arboviruses, particularly in re-
gions where Ae. albopictus and Ae. aegypti are present.
Ae. aegypti and Ae. albopictus are the main vectors of
DENV and CHIKV worldwide. Both mosquito species
have recently shown a large geographical expansion. Ae.
albopictus, known as the Asian tiger mosquito is among
the 100 of the world’s most invasive alien species [11]
and is currently present in many regions in the Ameri-
cas, Africa, Australia and Europe, where its presence
has been reported in several European countries, in-
cluding Switzerland [12–14]. In Brazil, Ae. albopictus
was recorded for the first time in 1986 and has since
spread throughout the country [15]. The rapid world-
wide expansion of Ae. albopictus is attributed to its
eggs that resist desiccation and may undergo diapause,
an adaptation to lower temperatures. Eggs are passively
dispersed across the globe through container shipments
of used tyres and wet plants [16, 17].
As a reaction to the dengue epidemics in Brazil, a na-
tional programme with the aim to eliminate Ae. aegypti
(Programa para Erradicação do Aedes aegypti) was
launched in 1996, and in 2002 it became the National
Programme for Dengue Control (Programa Nacional de
Controle de Dengue). The main goal of the programme
is to fight dengue through integrated vector control strat-
egies, including the use of larvicides [18]. Until 2008 the
main larvicide used in the programme was the organo-
phosphate temephos. Due to increasing resistance ob-
served in several Ae. aegypti populations [19–21]
temephos was replaced by the biological larvicide Bacil-
lus thuringiensis svar. israelensis (Bti) in some munici-
palities in 2002. Then, in 2009, it was replaced by the
insect growth regulators (i.e. chitin synthesis inhibitors),
diflubenzuron and novaluron [19, 22] and finally, be-
tween 2014 and 2015, by pyriproxyfen, a juvenile hor-
mone analogue [23]. Already in 2001, the health
secretary of the city of Recife had decided to use Bti as
the sole larvicide to fight Ae. aegypti. Bti equally targets
Ae. albopictus larvae that share the same breeding sites
with Ae. aegypti in many urban areas [24, 25] and, there-
fore, monitoring of Bti susceptibility to both Aedes spe-
cies is needed.
In Switzerland, Ae. albopictus was found for the first
time in the Canton of Ticino in the southernmost tip of
the country in 2003 [13]; its surveillance has since been
continuously expanded [26]. Today, the monitoring sys-
tem consists of more than 1000 ovitraps that are ana-
lysed bi-weekly and the trapping data are used to
coordinate targeted applications of insecticides [26]. In
addition, public information campaigns are carried out
in order to reduce breeding sites on private grounds. On
public grounds, where larval breeding sites may not be
removed (e.g. water drains), the authorities mainly apply
Bti and diflubenzuron for larval control. In addition,
focal spraying of permethrin to target adult mosquitoes
is implemented if there is a risk of autochthonous trans-
mission due to imported fever cases. Despite these ef-
forts, Ae. albopictus has expanded its range in the
Canton of Ticino over the last years [12, 26], requiring
careful monitoring of the current insecticides’ efficacy.
Bti formulations are widely used and shown to be ef-
fective in controlling mosquitoes [27–29]. The toxicity
of Bti against mosquito larvae is linked to crystals, pro-
duced during bacterial sporulation, that contain mainly
four protoxins Cry11Aa, Cry4Aa, Cry4Ba and Cyt1Aa
[30]. When ingested by mosquito larvae the crystals are
dissolved in the alkaline milieu of the midgut and the re-
leased protoxins are then activated into toxins by gut
proteases. The toxins bind to the receptors on the mid-
gut cell membranes, leading to the formation of pores
causing cell lysis, septicaemia and finally larval death
[31, 32]. Bti toxins are highly active due to their
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synergistic effects to the target species, while showing
low toxicity for other organisms due to their specificity
[33]. Bti may be used in combination with Lysinibacillus
sphaericus, another entomopathogen that also produces
insecticidal crystals. In combination, the toxins from
both bacteria display synergistic efficacy in a wide range
of mosquito species, including Aedes spp. [29].
This study was part of a Brazilian-Swiss Joint Research
Programme and aimed to examine whether the Ae. albo-
pictus populations in the Swiss-Italian border region and
in Recife are still fully susceptible to the insecticides cur-
rently applied despite their use over many years, in par-
ticular to Bti that has been widely employed in both
study areas. While Ae. albopictus is the only potential
vector of DENV, CHIKV and ZIKV in Switzerland, the
main vector in Brazil is Ae. aegypti and, therefore, in-
secticide susceptibility assays were done for both Aedes
species in Brazil. As there are no data available on adul-
ticides in Switzerland, additional WHO insecticide sus-
ceptibility bioassays were carried out. In Ticino,
Switzerland, a surveillance and control programme tar-
gets Ae. albopictus, such a programme does not exist in
the neighbouring Lombardy region in Italy; hence mos-
quitoes were collected from both areas and their insecti-
cide susceptibility compared.
Methods
Aedes susceptible reference colonies
Three Aedes colonies were used as susceptible reference
colonies for all the compounds tested in this study: (i)
Rockefeller, an international standard Ae. aegypti colony;
(ii) RecL, an Ae. aegypti colony established from eggs
collected from the Recife Metropolitan Region (RMR) in
1996 [34]; and (iii) RecLalb, an Ae. albopictus colony
established from eggs collected from the same area as
the RecL. The colonies were maintained in the insectary
of the Instituto Aggeu Magalhães in Recife, Brazil as
previously described [34]. Briefly, insects were main-
tained under controlled conditions at 26 ± 1 °C, 70%
relative humidity and a 14:10 h light:dark photoperiod.
Larvae were reared in de-chlorinated tap water and fed
with cat food (Whiskas®, Brazil). Adults were fed on a
10% sucrose solution and females were provided with
chicken blood twice per week.
Establishment of Aedes field colonies
The field colonies were set up from eggs collected in the
Canton of Ticino in southern Switzerland (TICINO), the
Province of Como Lombardy in northern Italy (COMO)
and from the Recife Metropolitan Region in Brazil, Sítio
dos Pintos (SP) and Recife “field” (RF). The eggs for the
TICINO and COMO colonies were provided by an
already existing network of 280 ovitraps that were set
across the Swiss-Italian border region [35]. The eggs
were collected from the wooden slats in the ovitraps
every other week between July and August 2013. To
hatch out the eggs the slats were transferred to trays
filled with de-chlorinated tap water. First-instar larvae
were then split into equally sized batches, transferred to
plastic trays and provided with TetraMin® fish food
(Tetra, Melle, Germany). The larval trays were kept in a
climate chamber (KBWF 720 E5.2, Binder GmbH,
Tuttlingen, Germany) at 28 °C, 70% relative humidity
and a 16:8 h light:dark photoperiod until pupation oc-
curred. Adults that emerged from the pupae were trans-
ferred to a 30 × 30 × 30 cm Bugdorm-1® insect cage
(Bugdorm, Taichung, Taiwan). Adults were allowed to
mate and had access to water and 10% sucrose solution
ad libitum. The founder populations of the TICINO and
COMO colonies consisted of 520 (380 females and 140
males) and 610 (330 females, 280 males) adult mosqui-
toes, respectively. The females were blood-fed twice per
week and their eggs collected on filter papers inside the
cage to produce the test population. In Brazil, eggs were
collected in 60 ovitraps distributed across Sítio dos Pin-
tos (SP), a district of Recife city and used to establish the
Ae. albopictus (SPalb) and Ae. aegypti (SPaeg) colonies,
as described in Regis et al. [36]. Upon eclosion, larvae
were maintained at the insectary of IAM-FIOCRUZ (Re-
cife, Brazil) as described above. SPalb and SPaeg colonies
were founded by 1774 (887 females and 887 males) and
3129 (1536 females and 1593 males) adult mosquitoes, re-
spectively. Recife Field (RF), another Ae. aegypti colony
representing 45 Recife districts was established from eggs
sampled using ovitraps that were set according to the
protocol previously described [37]. At least 1000 adults
from these field collections were used to set up the RF col-
ony. Bioassays were performed using larvae from the first
(F1), the second (F2) or, in exceptional cases, also the third
filial generation (F3).
Larval bioassays
In the larval bioassays, the microbacteria Bti, individual
Bti toxins and L. sphaericus as well as the chitin inhibit-
ing diflubenzuron were tested against the above Aedes
laboratory and field colonies (Table 1). Bti was prepared
from the lyophilized reference powder IPS82 (Pasteur
Institute, Paris, France), serotype H-14, as an aqueous
suspensions at 5 g/l, and stored at -20 °C until use. In
addition to Bti, individual Bti toxins, Cry11Aa and
Cry4Ba, were produced with the Bt acrystalliferous
strain 4Q2-81 that was transformed with plasmids carry-
ing the respective protoxin genes [38]. Cry11Aa and
Cry4Ba were chosen because they show the highest
larval toxicity among the major protoxins of the crystal
[39]. Spore-crystal biomass from each recombinant
strain was produced and then lyophilized according to
Barros et al. [40]. Similar to Bti an aqueous suspensions of
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L. sphaericus was prepared from lyophilized reference
powder SPH88 (Pasteur Institute, Paris, France), serotype
H5a5b strain 2362. Vectomax CG® (Valent Biosciences
Corporation, Libertyville, IL, USA) is a commercial prod-
uct available as water-soluble pouches containing a granu-
lar formulation that combines 4.5% Bti (serotype H-14,
strain AM65-52) and 2.7% L. sphaericus (2362, serotype
H5a5b, strain ABTS 1743) spores and insecticidal crystals
as active ingredients (AIs). To prepare the stock suspen-
sion of 70 g/l (i.e. 5 g/l of AI) pouches (batch 179,654 N8)
were incubated at 25 °C for 72 h in order to allow the re-
lease of crystals into the suspension. Aliquots of this sus-
pension were then stored at -20 °C until use. Dose-
response curves for Bti, Cry11Aa and Cry4Ba toxins, L.
sphaericus and Vectomax® were estimated following the
WHO guidelines for testing larvicides [41]. Briefly,
batches of 20 third-instar larvae were exposed to serial
dilutions of lyophilized spore-crystal powder in cups
containing 100 ml bacterial suspensions in distilled
water, without adding food. Five to seven concentra-
tions for each compound were tested in each bioassay
alongside a negative control group in three replicates.
The negative control group was only exposed to dis-
tilled water. Each bioassay was repeated at least three
times on different days. For Bti, Cry11Aa and Cry4Ba
mortality rates were recorded after a 24 h exposure and
for Vectomax® and L. sphaericus after a 48 h exposure
time.
In addition to the above larvicides, the efficacy of
diflubenzuron was assessed against the TICINO colony
because the compound is being used in the Ticino sur-
veillance and control programme [26]. The efficacy of
diflubenzuron to prevent adult emergence was assessed
in third-instar larvae as it inhibits the production of chi-
tin. For the bioassays diflubenzuron analytical standard
powder (Sigma-Aldrich: St. Louis, MO, USA, code
45446) was dissolved in acetone to make a 0.3% (w/v)
stock solution and aliquots were stored at -20 °C until
use. The bioassays then followed the protocols described
in Martins et al. [42]. Briefly, 8–12 concentrations, be-
tween 0.2 and 4.0 μg/l, were tested alongside a negative
control containing a 0.2% acetone in water solution. To
avoid starvation effects during the long term assay
period food was added to the test cups. Larvae were ex-
posed in 8 batches of 10, yielding 80 individuals at each
diflubenzuron concentration and in the negative control.
Any dead larva or pupa was removed from the bioassay
cups every other day and adult emergence was observed
up to 30 days. The assays were then repeated on different
days up to four times (Additional file 1: Tables S1-S3).
The mortality and inhibition rates were the basis to es-
timate dose-response curves in order to predict the aver-
age concentrations, and 95% confidence intervals, at
which 50% and 90% of the larval population would be
killed (i.e. LC50 and LC90) or, in the case of difluben-
zuron, prevented from reaching the adult stage (i.e. EI50
and EI90). The dose-response curves were estimated
using generalised linear models with a binomial distri-
bution and a “probit” link function. The models were
computed using the statistical software IBM SPSS 10.0
for Windows.
On the basis of the estimated LC50s and LC90s a resist-
ance ratio (RR) was calculated, where RR is the ratio be-
tween the LC for the test colony and the LC of the
reference colony. For chemical insecticides, Mazzarri &
Georghiou [43] proposed the following classifications:
low resistance for an RR below 5, moderate resistance
for an RR between 5 and 10, and high resistance for an
RR above 10. However, for biological compounds such
as Bti, RR values lower than 10-fold are considered as
natural variations [19, 44].
Adult bioassays
In addition to larvicides, the Ae. albopictus TICINO and
COMO colonies sampled from the Swiss-Italian border
region were also tested for their susceptibility against the
four insecticide classes of WHO recommended adulti-
cides. The insecticides evaluated were bendiocarb,
Table 1 Aedes spp. colonies and evaluated insecticides
Species Colony Source Insecticidal compound
Bti H-14 Cry11Aa Cry4Ba Vectomax® L. sphaericus Diflubenzuron Adulticidesa
Ae. albopictus RecLalb Lab. Brazil × × × × × – –
TICINO Field Switzerland × × × × – × ×
COMO Field Italy × × × × – – ×
SPalb Field Brazil × × × × – – –
Ae. aegypti Rockefeller Lab. Brazil × × × – – × –
RecL Lab. Brazil × – – – – – –
SPaeg Field Brazil × × × – – – –
RF Field Brazil × – – – – – –
aBendiocarb, DDT, malathion, permethrin (25:75 cis:trans ratio) and λ-cyhalothrin
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dichlorodiphenyltrichloroethane (DDT), malathion, the
non-alpha-cyanid pyrethroid permethrin (25:75 cis:trans
ratio) and the alpha-cyanoid pyrethroid λ-cyhalothrin
(Table 1). The pyrethroids were kindly provided by Syn-
genta Crop Protection (Basel, Switzerland), while the
other insecticides were purchased as technical grades
from Sigma-Aldrich. The bioassays were performed on
females of the F2 generation raised from the field-
sampled eggs following the WHO guidelines for testing
adulticides [45]. Using a series of insecticide-impregnated
filter papers, dose-response curves were estimated to de-
termine the lethal dosage (LD) that would kill 50% (LD50)
and 90% (LD90) of the TICINO and COMO colonies. The
filter papers (Whatman no. 1) were impregnated with in-
secticide in acetone solutions mixed with silicon oil (Dow
Corning 556 Silicon) according to the WHO test proce-
dures [46]. The insecticide solutions were serial dilutions
with five to six concentrations that would yield mortality
rates between 0 and 100%. In the test, batches of 17–25
non-blood-fed Ae. albopictus females, aged 2–5 days were
introduced into the exposure tubes lined with the
insecticide-treated filter papers. The mosquitoes were ex-
posed for 1 h, then gently blown back into the holding
tube and provided with 10% sucrose solution. Following a
24 h recovery period, the numbers of dead and alive mos-
quitoes were recorded. Mosquitoes were considered to be
alive if they were able to fly. Any knocked-down mosquito,
with or without legs and wings, were considered mori-
bund and were recorded as dead [45]. Tests were repeated
aiming at 100 mosquitoes exposed per insecticide and
concentration, including a negative control.
For the dose-response curves the 24 h mortality rates
were the basis to estimate the dosage at which 50% and
90% of the adult population would be killed (i.e. LD50
and LD90). The dose-response curves were estimated
using generalised linear models (GLM) with a binomial
distribution and a “logit” link function, predicting mor-
tality as a function of the log-transformed concentration.
The models were computed in the freely available soft-
ware package R, 3.3.2 [47] and the graph was produced
with the R package “ggplot2” [48].
Results
The susceptibility to Bti and its toxins was assessed for
each Aedes population as they are all being exposed to
Bti in the study areas. The Ae. albopictus populations
from the Canton of Ticino in southern Switzerland, the
Como area in northern Italy and Recife, Brazil were all
still susceptible to Bti. The LC50 values were similar with
a concentration of 0.015 mg/l, while the LC90 values var-
ied between 0.030–0.036 mg/l (Table 2). RRs between
the Ae. albopictus field colonies and RecLalb reference
colony were all below two-fold, showing that the field
populations remain fully susceptible to Bti. Likewise, the
LC values for SPaeg and RF, the two Ae. aegypti popula-
tions from Brazil were close to those observed for the
reference susceptible Rockefeller and the RecL colonies
(Table 2). The LC values for Bti across Ae. albopictus
and Ae. aegypti suggest that both species display a simi-
lar level of susceptibility to this agent.
In order to detect early development of resistance to
individual Bti toxins, lyophilized powders containing
Cry11Aa or Cry4Ba toxins were tested separately. Here,
the LC50 values of Cry11Aa and Cry4Ba against the Ae.
albopictus and Ae. aegypti field colonies were close to
those found for the corresponding reference colonies
(Table 3). The LC values of the selected Cry toxins were
an order of magnitude higher than those of the overall
Bti crystal, corroborating the Bti cocktail to be more ef-
fective than individual toxins.
The efficacy of L. sphaericus, another entomopatho-
genic bacterium, was tested against Ae. albopictus for
which the susceptibility status has been poorly docu-
mented, in contrast to Ae. aegypti that is well known to
be refractory. The reference powder SPH88 that contains
crystals of the binary (Bin) toxin from the 2362 strain
gave an LC50 of 0.084 mg/l and an LC90 of 0.336 mg/l in
the RecLalb reference colony (Table 4).
The activity of Vectomax®, a mixture of Bti and L.
sphaericus crystals, was also investigated in order to
evaluate if this combination of insecticidal components
could be an effective alternative to control Ae. albopic-
tus. Data from our evaluation showed similar LC values
for TICINO, COMO and SPalb Ae. albopictus colonies
(Table 4) and RRs below 2, suggesting Vectomax® to be
effective.
The third control agent that was tested against imma-
ture mosquito stages was diflubenzuron, a compound
used in Ticino to control Ae. albopictus [26] but neither
in Recife nor Como; hence the efficacy of diflubenzuron
was only evaluated against the TICINO colony. The EI50
preventing 50% larvae from developing into the adult
stage was 0.376 mg/l (95% confidence interval; 95% CI:
0.289–0.462 mg/l) and the EI90 was 1.197 mg/l (95% CI:
1.033–1.448 mg/l). These concentrations were similar to
those observed for the Ae. aegypti Rockefeller colony
that was used as a reference. Here, the EI50 was
0.456 mg/l (95% CI: 0.352–0.549 mg/l) and the EI90 was
1.655 mg/l (95% CI: 1.322–2.249 mg/l).
Finally, the two Ae. albopictus populations, COMO and
TICINO from the Swiss-Italian border region were also
tested against five insecticides, representing the four avail-
able classes of adulticides for which the susceptibility
status was unknown. Among the five insecticides λ-
cyhalothrin showed the lowest LC50, followed by bendio-
carb, permethrin, malathion and DDT (Table 5). The two
populations showed very similar dose-response profiles
(Fig. 1). Although there are no diagnostic concentrations
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available for Ae. albopictus, adult mortalities after a 1 h
exposure and 24 h holding period to bendiocarb, mala-
thion, permethrin and λ-cyhalothrin suggest that both
Ae. albopictus field populations are susceptible given
that the mortality rates were close to 100% at the diag-
nostic concentration for other mosquito species (Fig. 1)
and below those reported for permethrin and λ-
cyhalothrin in previous studies of field populations
[49, 50]. However, assuming Ae. aegypti to be a refer-
ence species, the COMO and TICINO colonies showed
decreased sensitivity to DDT as mortality rates at the Ae.
aegypti diagnostic concentration of 4% are estimated to be
96% for the TICINO and 96.9% for the COMO popula-
tion, even at the extended exposure time of 1 h. Note that,
according to WHO, the exposure time for Ae. aegypti
against DDT would only be 30 min [51].
The original data used in the statistical analysis are
provided in the Additional file 1: Tables S1-S3.
Discussion
In the absence of commercially available vaccines or treat-
ments, dengue, chikungunya, Zika and other arbovirus
transmissions may only be averted through vector control.
However, vector control heavily relies on insecticides,
raising concerns over the development of insecticide
resistance besides adverse effects on the environment and
human health [52]. Knowing the insecticide susceptibility
status of a local mosquito population is, therefore, crucial
[53]. Still, many programmes have been implemented
without previously evaluating the susceptibility pro-
files of the target field populations to the intended
control agents. In some cases, laboratory colonies
have been used as surrogates to establish the suscep-
tibility status, yet such colonies may underestimate
the existence of resistance alleles in the field due to
founder and bottle neck effects when maintaining la-
boratory colonies [44].
The biological larvicide Bti is known to be effective in
reducing mosquito densities in control programmes and
has a high toxicity to the target species without causing
unwanted side-effects to the environment [28, 54]. The
specificity of Bti is particularly important for the control
of mosquito species that breed in ecologically sensitive
areas where broad-spectrum insecticides may not be
used. Likewise, in urban settings the control of day-
active mosquito species like Ae. albopictus and Ae.
aegypti by adulticides is critical because of human ex-
posure to the insecticides. With the exception of one
case in Culex quinquefasciatus in New York, USA [55],
to our knowledge, no resistance to Bti has been reported
Table 2 Toxicity of Bacillus thuringiensis svar. israelensis (IPS82) against third-instar Aedes spp. larvae
Species Colony Number LC50 (95% CI)
a RRb LC90 (95% CI)
Ae. albopictus RecLalbb 1080 0.009 (0.008–0.011) – 0.028 (0.023–0.037)
TICINO 1440 0.015 (0.012–0.018) 1.7 0.036 (0.030–0.060)
COMO 1120 0.015 (0.012–0.016) 1.7 0.030 (0.026–0.036)
SPalb 1560 0.015 (0.011–0.020) 1.7 0.036 (0.027–0.098)
Ae. aegypti Rockefellerc 1320 0.008 (0.007–0.009) – 0.026 (0.021–0.036)
RecL 1080 0.013 (0.011–0.015) 1.6 0.032 (0.027–0.039)
SPaeg 1140 0.014 (0.012–0.016) 1.7 0.029 (0.025–0035)
RF 1860 0.013 (0.012–0.016) 1.6 0.037 (0.030–0.050)
aConcentration (mg/l) that is lethal to 50% or 90% of the larvae over a 24 h exposure, mean and 95% confidence interval
bResistance ratio (RR) between the LCs of the test colony and the reference colony
cReference colony
Table 3 Toxicity of Cry11Aa and Cry4Ba against third-instar Aedes spp. larvae
Cry11Aa Cry4Ba
Species Colony n LC50 (95% CI)
a RRb n LC50 (95% CI)
a RRc
Ae. albopictus RecLalbb 1500 0.410 (0.311–0.514) – 1380 0.595 (0.431–0.787) –
TICINO 1020 0.539 (0.437–0.648) 1.3 1440 0.483 (0.213–0.839) 0.8
COMO 1120 0.650 (0.517–0.798) 1.6 1060 0.782 (0.589–1.042) 1.3
SPalb 1500 0.432 (0.335–0.530) 1.1 980 0.830 (0.622–1.095) 1.4
Ae. aegypti Rockefellerc 1080 0.162 (0.121–0.210) – 1120 0.331 (0.209–0.492) –
SPaeg 1140 0.266 (0.207–0.339) 1.6 1140 0.685 (0.482–0.969) 2.1
aConcentration (mg/l) that is lethal for 50% or 90% of the larvae over a 24 h exposure, mean and 95% confidence interval
bResistance ratio (RR) between the LCs of the test colony and the reference colony
cReference colony
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from mosquito field populations [56–59] and decreased
larval susceptibility to Bti is also rare [60–62]. Under la-
boratory conditions resistance has been found to single
Bti toxins in selection experiments [63–65] but not to
Bti. With regards to the case of Bti resistance reported
from New York, it is inconclusive whether the observed
resistance is linked to the application of Bti as there are
neither data available from the pre-treatment period nor
has the finding been confirmed in a follow up study.
Here, we performed larval bioassays with Bti reference
powder IPS82 and two Bti toxins, Cry11Aa and Cry4Ba.
Our study showed no increased tolerance in any of the
Aedes populations and susceptibility was also similar be-
tween the intervention and the non-intervention areas
in the Swiss-Italian border. Also, the results from the
Aedes populations in Recife, Brazil suggest the exposure
to Bti for several years had not selected for insecticide
resistance. Comparing our results to the findings from
other studies it appears that variations in Bti susceptibil-
ity in Aedes spp. are narrow [19, 61, 66, 67]. Likewise,
our data show that Ae. albopictus and Ae. aegypti are
equally susceptible to Bti, suggesting that the same ap-
plication rates may be used where both species co-exist.
This is an important finding since Ae. albopictus can
be found in many urban environments together with
Ae. aegypti, and presence of both species in these
areas is being increasingly reported [24].
Tetreau et al. [65] stated that one of the main reasons
why no resistance to Bti has yet been detected in the
field is due to the synergistic effect of the individual
toxins which may mask failure of individual toxins. Pre-
vious laboratory studies have shown that exposure to
single Bti toxins selects for resistance but not when the
toxins are combined [64, 67–69]. In this study the ap-
proach of Tetreau et al. [65] was followed and bioassays
with two individual Bti toxins were performed with lar-
vae in order to have a more sensitive assay that may de-
tect early development of resistance. However, the
mosquito test populations were still fully susceptible
even to the individual Cry11Aa and Cry4Ba toxins. We,
therefore, conclude that Bti treatments in both Ticino,
Switzerland and Recife, Brazil have not exerted a selec-
tion pressure strong enough to cause a differential larval
response to these individual toxins.
Like Bti, L. sphaericus is a naturally occurring soil
bacterium that produces a larvicidal toxin [29]. The ef-
ficacy of L. sphaericus against Ae. albopictus has not
been well investigated; and was also assessed here in
order to account for the wide variations of L. sphaericus
toxicity generally observed in this genus [70–72]. For
Table 4 Lethal concentrations for Vectomax® and Lysinibacillus sphaericus (SPH88) against third-instar Aedes albopictus larvae
Larvicide Colony Number LC50
a
Mean (95% CI)
RRb LC90
a
Mean (95% CI)
RRb
Vectomax® RecLalb 1140 0.087 (0.080–0.094) – 0.163 (0.145–0.190) –
TICINO 1440 0.131 (0.118–0.144) 1.5 0.221 (0.194–0.228) 1.4
COMO 1120 0.076 (0.069–0.083) 0.9 0.145 (0.130–0.169) 0.9
SPalb 1260 0.092 (0.077–0.105) 1.1 0.191 (0.159–0.305) 1.2
L. sphaericus RecLalb 1080 0.084 (0.070–0.099) – 0.336 (0.239–0.630) –
aConcentration (mg/l) that is lethal for 50% or 90% of larvae over a 48 h exposure, mean and 95% confidence limits
bResistance ratio (RR) between the test colonies and the RecLalb reference colony
Table 5 Lethal concentrations for adulticides in Aedes albopictus from the Swiss-Italian border region
Insecticide Population Numbera LC50
b Mean (95% CI) LC90
b Mean (95% CI)
Bendiocarb TICINO 463 0.015 (0.014–0.017) 0.021 (0.019–0.024)
COMO 470 0.017 (0.016–0.019) 0.027 (0.024–0.031)
DDT TICINO 523 1.359 (1.220–1.514) 3.048 (2.557–3.635)
COMO 470 1.126 (1.003–1.263) 2.807 (2.309–3.413)
λ-cyhalothrin TICINO 440 0.007 (0.006–0.007) 0.012 (0.010–0.014)
COMO 426 0.006 (0.006–0.007) 0.011 (0.010–0.013)
Malathion TICINO 489 0.116 (0.104–0.128) 0.262 (0.222–0.310)
COMO 486 0.120 (0.108–0.133) 0.284 (0.239–0.338)
Permethrin TICINO 481 0.046 (0.042–0.051) 0.094 (0.081–0.110)
COMO 430 0.051 (0.047–0.056) 0.092 (0.079–0.106)
aTotal number of mosquitoes exposed across 5–6 concentrations
bConcentrations are expressed as % insecticide on the filter paper in the WHO insecticide susceptibility assay to kill 50% (LC50) and 90% (LC90) of the mosquito
population over a 24 h holding period
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Ae. albopictus we found LC values that were 8 to 13-
fold higher than that reported for C. quinquefasciatus
[73]. That is far better than the LC values for Ae.
aegypti, which are 100 to 1000-fold higher and, for this
reason, it is considered a refractory species [71]. When
comparing LC values of both bacteria towards Ae. albo-
pictus, L. sphaericus showed good activity since this
species was only 11-fold less susceptible compared to
Bti.
The biological larvicide Vectomax®, containing a mix-
ture of Bti and L. sphaericus crystals, was also evaluated
against Ae. albopictus since L. sphaericus activity can be
enhanced by Bti [74]. Vectomax® combines Bti’s advan-
tage of resistance-blocking together with L. sphaericus’
advantage of longer residuality in a single formulation
and a broader spectrum of action. Our evaluation shows
that Vectomax® is effective against Ae. albopictus, mak-
ing it an alternative for the control of immature stages
in our study areas. Conjugated products such as Vecto-
max® offer a mixture of 5 toxins that can target a wider
range of medically important insect species, while show-
ing a low risk of selection for resistance due to their
complex mode of action. Other studies evaluating of
Vectomax® in various environments have also shown its
efficacy [75–77]. In conclusion, Vectomax® is a promis-
ing candidate to replace the actual microbial larvicides
in our study areas.
Diflubenzuron showed to be another viable alternative
to control Ae. albopictus larvae given the low inhibitory
concentration found in the TICINO population, regard-
less of its history of utilisation in this area. Nevertheless,
application of diflubenzuron needs careful assessment
because it may harm non-target organisms.
In Ticino, the control of Ae. albopictus is mainly based
on larval source reduction, either by removing breeding
sites or by applying Bti or diflubenzuron if the larval
sources cannot be removed [26]. Adulticides are rarely
used. Only in exceptional cases is permethrin sprayed on
vegetation when mosquito densities cause nuisance to res-
idents in a confined area, or in surroundings from where
symptomatic patients with arboviral disease have been re-
ported [26]. Nevertheless, the susceptibility status of the
Swiss Ae. albopictus population has never been investi-
gated; and hence it is useful to know that permethrin
shows good activity against the local Ae. albopictus popu-
lation. While the results for permethrin, bendiocarb, λ-
cyhalothrin and malathion suggest that the Ae. albopictus
populations across the Swiss-Italian border region may be
considered susceptible to these insecticides, there are
some indications that the population shows decreased
susceptibility to DDT, or perhaps even resistance. Alter-
ation of susceptibility to DDT has also been recorded in
Ae. albopictus in Thailand, Japan, Malaysia, Cameroon
and the Central African Republic [49, 56, 78–80]; the
underlying mechanisms remain unclear.
In Brazil, although the use of adulticides have de-
creased due to their toxicity to humans, resistance to
most used compounds has already been widely docu-
mented in Aedes spp. populations [81, 82] and was not
further investigated in the present study.
Although we made some inference about adulticide
susceptibility in Ae. albopictus, we lack discriminating
concentrations for this mosquito species. However, with
its increasing importance for public health it would be
helpful to have explicit discriminating concentrations
also established for adulticides against Ae. albopictus.
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Fig. 1 Dose-response effects of adulticides in Aedes albopictus from the Swiss-Italian border region. The curves show the estimated dose-response
relationship between the 24 h mortality and the percentage insecticide on the filter paper in WHO insecticide susceptibility assays. The symbols
represent the summaries of the actual measurements in the bioassays, while the curves are the predicted estimates of the mean and the shaded areas
the 95% confidence intervals around the means. The vertical lines indicate the discriminating concentrations in Ae. aegypti for DDT, λ-cyhalothrin,
malathion and permethrin, and in Anopheles gambiae for bendiocarb, as there are no discriminating concentrations established for Ae. albopictus
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In summary, the Aedes populations evaluated in this
study were equally susceptible to the insecticides evalu-
ated. The study implies that the currently applied mos-
quito larvicides in Ticino, southern Switzerland as well
as in Recife, Brazil and adulticides in Ticino are still ef-
fective for the control of Ae. albopictus and Ae. aegypti.
The larvicides tested have distinct modes of action and
this feature is important to avoid the onset of resistance.
Besides the use of insecticides, other strategies show
promising results in decreasing vector densities and
should be considered as part of integrated mosquito
control programmes [83–87]. Highly productive artificial
breeding sites are often found on private properties [83]
and information campaigns encouraging the elimination
of these water containers, alongside a correct use of bio-
logical insecticides, can significantly decrease the local
mosquito population. The cost-effectiveness of such ap-
proaches and their long-term success should be evalu-
ated when compared with conventional control methods
[88]. Our results demonstrate the importance of re-
search on the susceptibility status of mosquito popula-
tions to insecticides to prevent the spread of resistance
in these important vectors of human diseases.
Conclusions
Currently used larvicides (i.e. Bti, diflubenzuron) and
adulticides (permethrin) used for mosquito control in the
Ticino and Recife control programmes remain effective
against the local Ae. albopictus and Ae. aegypti popula-
tions. The susceptibility profiles of the different mosquito
populations were similar, despite distinct differences in
the deployed interventions and geographical context. In
addition, Ae. albopictus and Ae. aegypti display similar
susceptibility levels to Bti, suggesting that this biolarvicide
may target both species where they co-exist.
Additional files
Additional file 1: Original data that were the basis for the statistical
analysis. Table S1. Mortalities recorded in the bioassays with
diflubenzuron. Table S2. Mortalities recorded in the bioassays with Bti,
and individual Bti toxins. Table S3. Mortalities recorded in the bioassays
with adulticides. (XLSX 122 kb)
Abbreviations
95% CI: 95% confidence interval; Bti: Bacillus thuringiensis svar. israelensis;
CHKV: Chikungunya virus; DDT: Dichlorodiphenyltrichloroethane;
DENV: Dengue virus; EI: Emergence inhibition; LC: Lethal concentration;
OP: Organophosphate; RR: Resistance ratio; ZIKV: Zika virus
Acknowledgements
The authors thank the insectary team at Instituto Aggeu Magalhães-FIOCRUZ
for technical support, the mosquito working group in Ticino for their
collaboration and Henry Owusu for guidance in performing WHO bioassays
in adult mosquitoes.
Funding
This study received funds from the Brazilian-Swiss Joint Research Programme
(Grant no. BJRP 0112-08), the Guggenheim-Schnurr Stiftung (Basel, Switzerland)
and the Conselho Nacional de Pesquisa (CNPq 590,154/2011-7, CNPq 472,491/
2012-1).
Availability of data and materials
All data generated or analysed during this study are included in this published
article and its additional files.
Authors’ contributions
TS, CMFO, MAVMS, RMRB, CFJA, MMC, LNR, PM and MHNLSF conceived the
study, designed and analysed the experimental data; TS, MMC, APA, MFO,
TSAP, MAVMS, MHNLSF, EF, and LE performed the experiments; TS, PM and
MHNLSF wrote the manuscript. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Epidemiology and Public Health, Swiss Tropical and Public
Health Institute, Socinstrasse 57, PO Box, 4002 Basel, Switzerland. 2University
of Basel, Petersplatz 1, 4003 Basel, Switzerland. 3Avia-GIS, Risschotlei 33, 2980
Zoersel, Belgium. 4Department of Entomology, Instituto Aggeu
Magalhães-FIOCRUZ, Recife 50740-465, Brazil. 5Laboratory of Applied
Microbiology, University of Applied Sciences and Arts of Southern
Switzerland, Bellinzona, Switzerland.
Received: 24 January 2017 Accepted: 7 September 2017
References
1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The
global distribution and burden of dengue. Nature. 2013;496:504–7.
2. Teixeira MG, Siqueira JB, Ferreira GLC, Bricks L, Joint G. Epidemiological
trends of dengue disease in Brazil (2000–2010): A systematic literature
search and analysis. PLoS Negl Trop Dis. 2013;7:e2520.
3. Secretaria de Vigilância em Saúde, Ministério da Saúde. Monitoramento dos
casos de dengue, febre de chikungunya e febre pelo vírus Zika até a
Semana Epidemiológica 52, 2016. Brazil: Secretaria de Vigilância em Saúde −
Ministério da Saúde; 2017.
4. Fares RCG, Souza KPR, Añez G, Rios M. Epidemiological scenario of dengue
in Brazil. Biomed Res Int. 2015;2015:321873.
5. Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, Bahia, Brazil. Emerg
Infect Dis. 2015;21:1885–6.
6. Angelini P, Macini P, Finarelli AC, Pol C, Venturelli C, Bellini R, et al.
Chikungunya epidemic outbreak in Emilia-Romagna (Italy) during summer
2007. Parassitologia. 2008;50:97–8.
7. Pialoux G, Gaüzère B-A, Jauréguiberry S, Strobel M. Chikungunya, an
epidemic arbovirosis. Lancet Infect Dis. 2007;7:319–27.
8. Delisle E, Rousseau C, Broche B, Leparc-Goffart I, L’ambert G, Cochet A, et al.
Chikungunya outbreak in Montpellier, France, September to October 2014.
Euro Surveill. 2015;20:21108.
9. Gjenero-Margan I, Aleraj B, Krajcar D, Lesnikar V, Klobučar A, Pem-Novosel I,
et al. Autochthonous dengue fever in Croatia, August-September 2010. Euro
Surveill. 2011;16:19805.
10. La Ruche G, Souarès Y, Armengaud A, Peloux-Petiot F, Delaunay P, Desprès
P, et al. First two autochthonous dengue virus infections in metropolitan
France, September 2010. Euro Surveill. 2010;15:19676.
Suter et al. Parasites & Vectors  (2017) 10:431 Page 9 of 11
11. Global Invasive Species Database. http://www.issg.org/database/species/
search.asp?st=100ss&fr=1&str=&lang=EN. Accessed 7 Dec 2012.
12. Flacio E, Engeler L, Tonolla M, Müller P. Spread and establishment of Aedes
albopictus in southern Switzerland between 2003 and 2014: an analysis of
oviposition data and weather conditions. Parasit Vectors. 2016;9:304.
13. Flacio E, Lüthy P, Patocchi N, Guidotti F, Tonolla M, Peduzzi R. Primo
ritrovamento di Aedes albopictus in Svizzera. Boll Della Soc Ticinese Sci Nat.
2004;92:141–2.
14. ECDC. VBORNET Mosquito maps. European Centre for Disease Control and
Prevention. 2017. http://www.ecdc.europa.eu/en/healthtopics/vectors/
vector-maps/Pages/VBORNET_maps.aspx. Accessed 5 Jul 2017.
15. dos Santos RLC. Updating of the distribution of Aedes albopictus in Brazil
(1997). Rev Saúde Pública. 2003;37:5.
16. Scholte E-J, Jacobs F, Linton Y-M, Dijkstra E, Fransen J, Takken W. First
record of Aedes (Stegomyia) albopictus in the Netherlands. Eur Mosq
Bull. 2007;22:5–9.
17. Reiter P, Sprenger D. The used tire trade: a mechanism for the worldwide
dispersal of container breeding mosquitoes. J Am Mosq Control Assoc.
1987;3:494–501.
18. Braga IA, Valle D. Aedes aegypti: histórico do controle no Brasil. Epidemiol E
Serviços Saúde. 2007;16:113–8.
19. Araújo AP, Araujo Diniz DF, Helvecio E, de Barros RA, de Oliveira CMF, CFJ A,
et al. The susceptibility of Aedes aegypti populations displaying temephos
resistance to Bacillus thuringiensis israelensis: a basis for management. Parasit
Vectors. 2013;6:297.
20. Lima EP, Santos Paiva MH, de Araujo AP, Gomes da Silva EV, da Silva UM, de
Oliveira LN, et al. Insecticide resistance in Aedes aegypti populations from
Ceara, Brazil. Parasit Vectors. 2011;4:5.
21. Macoris Mde LG, MTM A, Takaku L, Glasser CM, Garbeloto VC, Bracco JE.
Resistance of Aedes aegypti from the state of São Paulo, Brazil, to
organophosphates insecticides. Mem Inst Oswaldo Cruz. 2003;98:703–8.
22. Secretaria de Vigilância em Saúde. Nota Técnica no 015/2009/CGPNCD/
DIGES/SVS/MS. Brasília: Ministério da Saúde; 2009.
23. Secretaria de Vigilância em Saúde. Nota Técnica no 123/2014/GAB/SVS/MS.
Brasília: Ministério da Saúde; 2014.
24. Carvalho RG, Lourenço-de-Oliveira R, Braga IA. Updating the geographical
distribution and frequency of Aedes albopictus in Brazil with remarks
regarding its range in the Americas. Mem Inst Oswaldo Cruz. 2014;109:
787–96.
25. de Albuquerque CM, Melo-Santos MAV, Bezerra MAS, Barbosa RM, Silva DF,
da Silva E. First report of Aedes albopictus in areas of rain forest in Brazil. Rev
Saúde Pública. 2000;34:314–5.
26. Flacio E, Engeler L, Tonolla M, Lüthy P, Patocchi N. Strategies of a thirteen
year surveillance programme on Aedes albopictus (Stegomyia albopicta) in
southern Switzerland. Parasit Vectors. 2015;8:208.
27. Becker N. Microbial control of mosquitoes: management of the Upper Rhine
mosquito population as a model programme. Parasitol Today. 1997;13:485–7.
28. Guidi V, Patocchi N, Lüthy P, Tonolla M. Distribution of Bacillus thuringiensis
subsp. israelensis in Soil of a Swiss Wetland reserve after 22 years of mosquito
control. Appl Environ Microbiol. 2011;77:3663–8.
29. Lacey LA. Bacillus thuringiensis serovariety israelensis and Bacillus sphaericus
for mosquito control. J Am Mosq Control Assoc. 2007;23:133–63.
30. Berry C, O’Neil S, Ben-Dov E, Jones AF, Murphy L, Quail MA, et al.
Complete sequence and organization of pBtoxis, the toxin-coding
plasmid of Bacillus thuringiensis subsp. israelensis. Appl Environ
Microbiol. 2002;68:5082–95.
31. de Maagd RA, Bravo A, Crickmore N. How Bacillus thuringiensis has evolved
specific toxins to colonize the insect world. Trends Genet. 2001;17:193–9.
32. Gómez I, Pardo-López L, Muñoz-Garay C, Fernandez LE, Pérez C, Sánchez J,
et al. Role of receptor interaction in the mode of action of insecticidal Cry
and Cyt toxins produced by Bacillus thuringiensis. Peptides. 2007;28:169–73.
33. Thomas WE, Ellar DJ. Mechanism of action of Bacillus thuringiensis var
israelensis insecticidal delta-endotoxin. FEBS Lett. 1983;154:362–8.
34. de Melo-Santos MAV, de Araújo AP, Rios EMM, Regis L. Long lasting
persistence of Bacillus thuringiensis serovar. israelensis larvicidal activity in
Aedes aegypti (Diptera: Culicidae) breeding places is associated to bacteria
recycling. Biol Control. 2009;49:186–91.
35. Suter TT, Flacio E, Fariña BF, Engeler L, Tonolla M, Regis LN, et al. Surveillance
and control of Aedes albopictus in the Swiss-Italian border region: differences in
egg densities between intervention and non-intervention areas. PLoS Negl
Trop Dis. 2016;10:e0004315.
36. Regis L, Monteiro AM, de Melo-Santos MAV, Silveira JC Jr, Furtado AF, Acioli
RV, et al. Developing new approaches for detecting and preventing Aedes
aegypti population outbreaks: basis for surveillance, alert and control
system. Mem Inst Oswaldo Cruz. 2008;103:50–9.
37. Secretaria de Vigilância em Saúde. Rede Nacional de Montoramento da
Resistência de Aedes aegypti a inseticidas (Rede MoReNAa): metodologia de
amostragem. Brasília: Ministério da Saúde; 2008.
38. Delécluse A, Poncet S, Klier A, Rapoport G. Expression of cryIVA and cryIVB
genes, independently or in combination, in a crystal-negative strain of Bacillus
thuringiensis subsp. israelensis. Appl Environ Microbiol. 1993;59:3922–7.
39. Crickmore N, Bone EJ, Williams JA, Ellar DJ. Contribution of the individual
components of the δ-endotoxin crystal to the mosquitocidal activity of
Bacillus thuringiensis subsp. israelensis. FEMS Microbiol Lett. 1995;131:249–54.
40. de Barros Moreira Beltrão H, Silva-Filha MHNL. Interaction of Bacillus
thuringiensis svar. israelensis Cry toxins with binding sites from Aedes aegypti
(Diptera: Culicidae) larvae midgut. FEMS Microbiol Lett. 2007;266:163–9.
41. WHO. Guidelines for laboratory and field testing of mosquito larvicides.
Geneva: World Health Organization; 2005.
42. Martins AJ, Belinato TA, Lima JBP, Valle D. Chitin synthesis inhibitor effect on
Aedes aegypti populations susceptible and resistant to organophosphate
temephos. Pest Manag Sci. 2008;64:676–80.
43. Mazzarri MB, Georghiou GP. Characterization of resistance to organophosphate,
carbamate, and pyrethroid insecticides in field populations of Aedes aegypti
from Venezuela. J Am Mosq Control Assoc. 1995;11:315–22.
44. Robertson JL, Preisler HK, Ng SS, Hickle LA, Gelernter WD. Natural variation:
A complicating factor in bioassays with chemical and microbial pesticides.
J Econ Entomol. 1995;88:1–10.
45. WHO. Test procedures for insecticide resistance monitoring in malaria vector
mosquitoes. Geneva: World Health Organization; 2013.
46. WHO. Guidelines for testing mosquito adulticides for indoor residual spraying
and treatment of mosquito nets. Geneva: World Health Organization; 2006.
47. R Development Core Team. R: A Language and Environment for Statistical
Computing. Vienna; 2011. http://www.R-project.org . Accessed 21 June
2016.
48. Wickham H. ggplot2: Elegant Graphics for Data Analysis. 2nd ed: New York:
Springer Nature; 2016.
49. Ishak IH, Jaal Z, Ranson H, Wondji CS. Contrasting patterns of insecticide
resistance and knockdown resistance (kdr) in the dengue vectors Aedes
aegypti and Aedes albopictus from Malaysia. Parasit Vectors. 2015;8:181.
50. Sivan A, Shriram AN, Sunish IP, Vidhya PT. Studies on insecticide susceptibility
of Aedes aegypti (Linn) and Aedes albopictus (Skuse) vectors of dengue
and chikungunya in Andaman and Nicobar Islands. India Parasitol Res.
2015;114:4693–702.
51. WHO Pesticide Evaluation Scheme. Discriminating concentrations of
insecticides for adult mosquitoes; 2016.
52. van den Berg H, Zaim M, Yadav RS, Soares A, Ameneshewa B, Mnzava A, et
al. Global trends in the use of insecticides to control vector-borne diseases.
Environ Health Perspect. 2012;120:577–82.
53. Pocquet N, Darriet F, Zumbo B, Milesi P, Thiria J, Bernard V, et al. Insecticide
resistance in disease vectors from Mayotte: an opportunity for integrated
vector management. Parasit Vectors. 2014;7:299.
54. Becker N. The use of Bacillus thuringiensis subsp. israelensis (Bti) against
mosquitoes, with special emphasis on the ecological impact. Isr J Entomol.
1998;32:63–9.
55. Paul A, Harrington LC, Zhang L, Scott JG. Insecticide resistance in Culex pipiens
from New York. J Am Mosq Control Assoc. 2005;21:305.
56. Kamgang B, Marcombe S, Chandre F, Nchoutpouen E, Nwane P, Etang J, et
al. Insecticide susceptibility of Aedes aegypti and Aedes albopictus in Central
Africa. Parasit Vectors. 2011;4:79.
57. Liu H, Cupp EW, Guo A, Liu N. Insecticide resistance in Alabama and Florida
mosquito strains of Aedes albopictus. J Med Entomol. 2004;41:946–52.
58. Loke SR, Andy-Tan WA, Benjamin S, Lee HL, Sofian-Azirun M. Susceptibility
of field-collected Aedes aegypti (L.) (Diptera: Culicidae) to Bacillus
thuringiensis israelensis and temephos. Trop Biomed. 2010;27:493–503.
59. Vasquez MI, Violaris M, Hadjivassilis A, Wirth MC. Susceptibility of Culex
pipiens (Diptera: Culicidae) field populations in Cyprus to conventional
organic insecticides, Bacillus thuringiensis subsp. israelensis, and methoprene.
J Med Entomol. 2009;46:881–7.
60. Boyer S, Paris M, Jego S, Lemperiere G, Ravanel P. Influence of insecticide Bacillus
thuringiensis subsp israelensis treatments on resistance and enzyme activities in
Aedes rusticus larvae (Diptera: Culicidae). Biol Control. 2012;62:75–81.
Suter et al. Parasites & Vectors  (2017) 10:431 Page 10 of 11
61. Boyer S, Tilquin M, Ravanel P. Differential sensitivity to Bacillus thuringiensis var.
israelensis and temephos in field mosquito populations of Ochlerotatus cataphylla
(Diptera: Culicidae): toward resistance? Environ Toxicol Chem. 2007;26:157–62.
62. Hongyu Z, Changju Y, Jingye H, Lin L. Susceptibility of field populations of
Anopheles sinensis (Diptera: Culicidae) to Bacillus thuringiensis subsp.
israelensis. Biocontrol Sci Tech. 2004;14:321–5.
63. Cadavid-Restrepo G, Sahaza J, Orduz S. Treatment of an Aedes aegypti colony
with the Cry11Aa toxin for 54 generations results in the development of
resistance. Mem Inst Oswaldo Cruz. 2012;107:74–9.
64. Georghiou GP, Wirth MC. Influence of exposure to single versus multiple
toxins of Bacillus thuringiensis subsp. israelensis on development of
resistance in the mosquito Culex quinquefasciatus (Diptera: Culicidae). Appl
Environ Microbiol. 1997;63:1095–101.
65. Tetreau G, Stalinski R, David J-P, Després L. Monitoring resistance to Bacillus
thuringiensis subsp. israelensis in the field by performing bioassays with each
Cry toxin separately. Mem Inst Oswaldo Cruz. 2013;108:894–900.
66. Marcombe S, Farajollahi A, Healy SP, Clark GG, Fonseca DM. Insecticide
resistance status of United States populations of Aedes albopictus and
mechanisms involved. PLoS One. 2014;9:e101992.
67. Wirth MC. Mosquito resistance to bacterial larvicidal toxins. Open Toxinology J.
2010;3:126–40.
68. Paris M, Tetreau G, Laurent F, Lelu M, Despres L, David J-P. Persistence of
Bacillus thuringiensis israelensis (Bti) in the environment induces resistance to
multiple Bti toxins in mosquitoes. Pest Manag Sci. 2011;67:122–8.
69. Wirth MC, Walton WE, Federici BA. Inheritance patterns, dominance, stability,
and allelism of insecticide resistance and cross-resistance in two colonies of
Culex quinquefasciatus (Diptera: Culicidae) selected with Cry toxins from
Bacillus thuringiensis subsp. israelensis. J Med Entomol. 2012;49:886–94.
70. Berry C, Hindley J, Ehrhardt AF, Grounds T, De Souza I, Davidson EW. Genetic
determinants of host ranges of Bacillus sphaericus mosquito larvicidal toxins.
J Bacteriol. 1993;175:510–8.
71. Thiery I, de Barjac H. Selection of the most potent Bacillus sphaericus strains
based on activity ratios determined on three mosquito species. Appl
Microbiol Biotechnol. 1989;31:577–81.
72. Wraight SP, Molloy DP, Singer S. Studies on the culicine mosquito host range
of Bacillus sphaericus and Bacillus thuringiensis var israelensis with notes on the
effects of temperature and instar on bacterial efficacy. J Invertebr Pathol.
1987;49:291–302.
73. Chalegre KDM, Romao TP, Amorim LB, Anastacio DB, de Barros RA, de
Oliveira CMF, et al. Detection of an allele conferring resistance to Bacillus
sphaericus binary toxin in Culex quinquefasciatus populations by molecular
screening. Appl Environ Microbiol. 2009;75:1044–9.
74. Wirth MC, Jiannino JA, Federici BA, Walton WE. Synergy between toxins of
Bacillus thuringiensis subsp. israelensis and Bacillus sphaericus. J Med Entomol.
2004;41:935–41.
75. Anderson JF, Ferrandino FJ, Dingman DW, Main AJ, Andreadis TG, Becnel JJ.
Control of mosquitoes in catch basins in Connecticut with Bacillus thuringiensis
israelensis, Bacillus sphaericus, and spinosad. J Am Mosq Control Assoc.
2011;27:45–55.
76. Dritz DA, Lawler SP, Evkhanian C, Graham P, Baracosa V, Dula G. Control of
mosquito larvae in seasonal wetlands on a wildlife refuge using Vectomax™
CG. J Am Mosq Control Assoc. 2011;27:398–403.
77. Eritja R. Laboratory tests on the efficacy of VBC60035, a combined larvicidal
formulation of Bacillus thuringiensis israelensis (Strain AM65-52) and Bacillus
sphaericus (Strain 2362) against Aedes albopictus in simulated catch basins.
J Am Mosq Control Assoc. 2013;29:280–3.
78. Kawada H, Maekawa Y, Abe M, Ohashi K, Ohba S, Takagi M. Spatial distribution
and pyrethroid susceptibility of mosquito larvae collected from catch basins in
parks in Nagasaki City, Nagasaki, Japan. Jpn J Infect Dis. 2010;63:19–24.
79. Somboon P, Prapanthadara L, Suwonkerd W. Insecticide susceptibility tests
of Anopheles minimus s.l., Aedes aegypti, Aedes albopictus, and Culex
quinquefasciatus in northern Thailand. Southeast Asian J Trop Med Public
Health. 2003;34:87–93.
80. Ngoagouni C, Kamgang B, Brengues C, Yahouedo G, Paupy C, Nakouné E,
et al. Susceptibility profile and metabolic mechanisms involved in Aedes
aegypti and Aedes albopictus resistant to DDT and deltamethrin in the
Central African Republic. Parasit Vectors. 2016;9:599.
81. Macoris MLG, Andrighetti MTM, Wanderley DMV, Ribolla PEM. Impact of
insecticide resistance on the field control of Aedes aegypti in the State of
São Paulo. Rev Soc Bras Med Trop. 2014;47:573–8.
82. Bellinato DF, Viana-Medeiros PF, Araújo SC, Martins AJ, Lima JBP, Valle D.
Resistance status to the insecticides temephos, deltamethrin, and
diflubenzuron in Brazilian Aedes aegypti populations. Biomed Res Int. 2016:
8603263.
83. Bartlett-Healy K, Unlu I, Obenauer P, Hughes T, Healy S, Crepeau T, et al. Larval
mosquito habitat utilization and community dynamics of Aedes albopictus and
Aedes japonicus (Diptera: Culicidae). J Med Entomol. 2012;49:813–24.
84. Carvalho DO, McKemey AR, Garziera L, Lacroix R, Donnelly CA, Alphey L, et
al. Suppression of a field population of Aedes aegypti in Brazil by sustained
release of transgenic male mosquitoes. PLoS Negl Trop Dis. 2015;9:e0003864.
85. Hoffmann AA, Montgomery BL, Popovici J, Iturbe-Ormaetxe I, Johnson PH,
Muzzi F, et al. Successful establishment of Wolbachia in Aedes populations
to suppress dengue transmission. Nature. 2011;476:454–7.
86. Marten GG, Reid JW. Cyclopoid copepods. J Am Mosq Control Assoc.
2007;23:65–92.
87. Vanlerberghe V, Toledo ME, Rodríguez M, Gómez D, Baly A, Benítez JR, et al.
Community involvement in dengue vector control: cluster randomised trial.
BMJ. 2009;338:b1959.
88. Fonseca DM, Unlu I, Crepeau T, Farajollahi A, Healy SP, Bartlett-Healy K, et al.
Area-wide management of Aedes albopictus. Part 2: Gauging the efficacy
of traditional integrated pest control measures against urban container
mosquitoes. Pest Manag Sci. 2013;69:1351–61.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Suter et al. Parasites & Vectors  (2017) 10:431 Page 11 of 11
